PDB42 INCRETIN-THERAPY IN ADDITION TO METFORMIN AND/OR SULFONYLUREA FOR TYPE 2 DIABETES MELLITUS (T2DM): COSTEFFECTIVENESS OF LIRAGLUTIDE VERSUS EXENATIDE FROM THE PERSPECTIVE OF THE GERMAN STATUTORY HEALTH INSURANCE (SHI)

✍ Scribed by M Schlander; S Mentrup; N Lund

• Book ID: 118614295
• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 71 KB
• Volume: 13
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(11)72100-3